全文获取类型
收费全文 | 11604篇 |
免费 | 709篇 |
国内免费 | 27篇 |
专业分类
耳鼻咽喉 | 95篇 |
儿科学 | 221篇 |
妇产科学 | 217篇 |
基础医学 | 1550篇 |
口腔科学 | 247篇 |
临床医学 | 1494篇 |
内科学 | 2130篇 |
皮肤病学 | 73篇 |
神经病学 | 1082篇 |
特种医学 | 376篇 |
外科学 | 1512篇 |
综合类 | 126篇 |
一般理论 | 12篇 |
预防医学 | 1353篇 |
眼科学 | 218篇 |
药学 | 932篇 |
中国医学 | 13篇 |
肿瘤学 | 689篇 |
出版年
2023年 | 78篇 |
2022年 | 95篇 |
2021年 | 211篇 |
2020年 | 157篇 |
2019年 | 218篇 |
2018年 | 284篇 |
2017年 | 203篇 |
2016年 | 212篇 |
2015年 | 272篇 |
2014年 | 372篇 |
2013年 | 546篇 |
2012年 | 873篇 |
2011年 | 926篇 |
2010年 | 504篇 |
2009年 | 510篇 |
2008年 | 833篇 |
2007年 | 866篇 |
2006年 | 865篇 |
2005年 | 871篇 |
2004年 | 866篇 |
2003年 | 742篇 |
2002年 | 725篇 |
2001年 | 90篇 |
2000年 | 74篇 |
1999年 | 94篇 |
1998年 | 138篇 |
1997年 | 121篇 |
1996年 | 83篇 |
1995年 | 62篇 |
1994年 | 56篇 |
1993年 | 53篇 |
1992年 | 33篇 |
1991年 | 22篇 |
1990年 | 26篇 |
1989年 | 28篇 |
1988年 | 18篇 |
1987年 | 22篇 |
1986年 | 19篇 |
1985年 | 23篇 |
1984年 | 20篇 |
1983年 | 23篇 |
1982年 | 19篇 |
1981年 | 21篇 |
1980年 | 16篇 |
1979年 | 4篇 |
1978年 | 10篇 |
1977年 | 8篇 |
1976年 | 10篇 |
1975年 | 5篇 |
1972年 | 3篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
91.
Association of interleukin-6 -174G/C promoter polymorphism with hypertension and left ventricular hypertrophy in dialysis patients 总被引:5,自引:0,他引:5
BACKGROUND: Gene polymorphisms of proinflammatory cytokines, such as interleukin-6 (IL-6) and the chemokine receptor CX3CR1, have been found in association with cardiovascular disease in the general population. In dialysis patients, in whom the prevalence of cardiovascular comorbidity is strikingly high, these polymorphisms have not been investigated. METHODS: The -174G/C polymorphism of the IL-6 gene and the chemokine receptor CX3CR1 polymorphisms 249V/I and 280T/M were examined for their association with cardiovascular abnormalities in a cohort of 161 patients with end-stage renal disease (ESRD) treated by hemodialysis. Arterial blood pressure, electrocardiogram (ECG) ischemic changes, and left ventricular mass index (LVMI) were the parameters examined for the association study. The control group was made up of 169 healthy subjects. RESULTS: We found that for both IL-6 and chemokine receptor, genotype frequency and allelic distribution in both ESRD patients and controls were comparable. The genetic association study showed that in the whole group of dialysis patients, individuals with GC + CC genotype for the -174G/C polymorphism had a higher diastolic blood pressure (P = 0.008) and LVMI (P = 0.026) than GG homozygotes. The prevalence of left ventricular hypertrophy (LVH) in the former group was 58.6% vs. 39.2% in the latter (P = 0.02). The same analysis limited to diabetic patients in dialysis, showed that the prevalence of LVH in those with CG + CC genotype was 87.5% vs. 36.3% in those with GG genotype (P = 0.02). In diabetic patients, lower levels of serum albumin was found in the GC + CC genotypic group than in GG subjects; 34.63 +/- 5.18 g/L vs. 41.75 +/- 4.79 g/L (P = 0.003). CONCLUSION: These data demonstrate an association between the IL-6 promoter polymorphism -174G/C and high blood pressure and LVH in hemodialysis patients, especially those with diabetes. The results strengthen the hypothesis that chronic inflammation is a mechanism of cardiovascular damage in dialysis patients and the role played by the IL-6 system in this mechanism. 相似文献
92.
A novel Syk-dependent mechanism of platelet activation by the C-type lectin receptor CLEC-2 下载免费PDF全文
Suzuki-Inoue K Fuller GL García A Eble JA Pöhlmann S Inoue O Gartner TK Hughan SC Pearce AC Laing GD Theakston RD Schweighoffer E Zitzmann N Morita T Tybulewicz VL Ozaki Y Watson SP 《Blood》2006,107(2):542-549
The snake venom rhodocytin has been reported to bind to integrin alpha2beta1 and glycoprotein (GP) Ibalpha on platelets, but it is also able to induce activation independent of the 2 receptors and of GPVI. Using rhodocytin affinity chromatography, we have identified a novel C-type lectin receptor, CLEC-2, in platelets that confers signaling responses to rhodocytin when expressed in a cell line. CLEC-2 has a single tyrosine residue in a YXXL motif in its cytosolic tail, which undergoes tyrosine phosphorylation upon platelet activation by rhodocytin or an antibody to CLEC-2, but not to collagen, thrombin receptor agonist peptide (TRAP), or convulxin. Tyrosine phosphorylation of CLEC-2 and other signaling proteins by rhodocytin is inhibited by the Src family kinase inhibitor PP2. Further, activation of murine platelets by rhodocytin is abolished in the absence of Syk and PLCgamma2, and partially reduced in the absence of LAT, SLP-76, and Vav1/Vav3. These findings define a novel signaling pathway in platelets whereby activation of CLEC-2 by rhodocytin leads to tyrosine phosphorylation of its cytosolic tail, binding of Syk and initiation of downstream tyrosine phosphorylation events, and activation of PLCgamma2. CLEC-2 is the first C-type lectin receptor to be found on platelets which signals through this novel pathway. 相似文献
93.
94.
95.
Hector S. Izurieta Patrick Zuber Jan Bonhoeffer Robert T. Chen Osman Sankohg Kayla F. Laserson Miriam Sturkenboom Christian Loucq Daniel Weibel Caitlin Dodd Steve Black 《Vaccine》2013
With the advent of new vaccines targeted to highly endemic diseases in low- and middle-income countries (LMIC) and with the expansion of vaccine manufacturing globally, there is an urgent need to establish an infrastructure to evaluate the benefit-risk profiles of vaccines in LMIC. Fortunately the usual decade(s)-long time gap between introduction of new vaccines in high and low income countries is being significantly reduced or eliminated due to initiatives such as the Global Alliance for Vaccines and Immunizations (GAVI) and the Decade of Vaccines for the implementation of the Global Vaccine Action Plan. While hoping for more rapid disease control, this time shift may potentially add risk, unless appropriate capacity for reliable and timely evaluation of vaccine benefit-risk profiles in some LMIC's are developed with external assistance from regional or global level. An ideal vaccine safety and effectiveness monitoring system should be flexible and sustainable, able to quickly detect possible vaccine-associated events, distinguish them from programmatic errors, reliably and quickly evaluate the suspected event and its association with vaccination and, if associated, determine the benefit-risk of vaccines to inform appropriate action. Based upon the demonstrated feasibility of active surveillance in LMIC as shown by the Burkina Faso assessment of meningococcal A conjugate vaccine or that of rotavirus vaccine in Mexico and Brazil, and upon the proof of concept international GBS study, we suggest a sustainable, flexible, affordable and timely international collaborative vaccine safety monitoring approach for vaccines being newly introduced. While this paper discusses only the vaccine component, the same system could also be eventually used for monitoring drug effectiveness (including the use of substandard drugs) and drug safety. 相似文献
96.
97.
98.
99.
100.
Gregory Welter PE BCEE Myra Socher BS EMT/P Patricia Needham MT HEM Steve Bieber MS MPA Heidi Bonnaffon MS 《Journal of healthcare risk management》2013,32(4):5-14
The purpose of this article is to outline the criticality of water supply in sustained operations of healthcare facilities, particularly during community emergencies, and to advocate for enhanced cross‐sector support from the water utilities in meeting this need. Information and ideas presented here were developed in the course of a regional project sponsored by the Metropolitan Washington Council of Governments (MWCOG) for development of emergency water supply operations plans for critical water uses in the Washington, DC, area. 相似文献